CLG561
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CLG561, covering 2016-03-25 to 2018-12-19. Get the full timeline:
Most recent: Clinical Trial Update: CLG561 Proof-of-Concept Study as a Monotherapy and in Combination With LFG316 in Subjects With Geographic Atrophy (GA) [Phase 2]